235 related articles for article (PubMed ID: 15963302)
1. Rifampin-resistant meningococcal disease.
Rainbow J; Cebelinski E; Bartkus J; Glennen A; Boxrud D; Lynfield R
Emerg Infect Dis; 2005 Jun; 11(6):977-9. PubMed ID: 15963302
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of resistance to rifampicin in clinical isolates of Neisseria meningitidis.
Skoczynska A; Ruckly C; Hong E; Taha MK
Clin Microbiol Infect; 2009 Dec; 15(12):1178-81. PubMed ID: 19456827
[TBL] [Abstract][Full Text] [Related]
3. Rifampin-resistant Neisseria meningitidis.
Taha MK; Zarantonelli ML; Ruckly C; Giorgini D; Alonso JM
Emerg Infect Dis; 2006 May; 12(5):859-60. PubMed ID: 16710955
[No Abstract] [Full Text] [Related]
4. Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America.
Wu HM; Harcourt BH; Hatcher CP; Wei SC; Novak RT; Wang X; Juni BA; Glennen A; Boxrud DJ; Rainbow J; Schmink S; Mair RD; Theodore MJ; Sander MA; Miller TK; Kruger K; Cohn AC; Clark TA; Messonnier NE; Mayer LW; Lynfield R
N Engl J Med; 2009 Feb; 360(9):886-92. PubMed ID: 19246360
[TBL] [Abstract][Full Text] [Related]
5. Surveillance of antimicrobial resistance in Neisseria meningitidis strains isolated from invasive cases in Brazil from 2009 to 2016.
Gorla MC; Pinhata JMW; Dias UJ; de Moraes C; Lemos AP
J Med Microbiol; 2018 Jun; 67(6):750-756. PubMed ID: 29717974
[TBL] [Abstract][Full Text] [Related]
6. Emergence of fluoroquinolone-resistant Neisseria meningitidis--Minnesota and North Dakota, 2007-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(7):173-5. PubMed ID: 18288075
[TBL] [Abstract][Full Text] [Related]
7. Invasive meningococcal disease due to ciprofloxacin-resistant Neisseria meningitidis sequence type 4821: The first case in Japan.
Kawasaki Y; Matsubara K; Takahashi H; Morita M; Ohnishi M; Hori M; Isome K; Iwata A; Nigami H; Ikemachi M; Yamamoto G; Ohkusu K
J Infect Chemother; 2018 Apr; 24(4):305-308. PubMed ID: 29233459
[TBL] [Abstract][Full Text] [Related]
8. Management of a rifampicin-resistant meningococcal infection in a teenager.
Delaune D; Andriamanantena D; Mérens A; Viant E; Aoun O; Ceppa F; Taha MK; Rapp C
Infection; 2013 Jun; 41(3):705-8. PubMed ID: 23408002
[TBL] [Abstract][Full Text] [Related]
9. Meningococcemia in identical twins: changes in serum susceptibility after rifampin chemoprophylaxis.
Levy DI; del Rio C; Stephens DS
J Infect Dis; 1988 May; 157(5):1064-8. PubMed ID: 3129520
[No Abstract] [Full Text] [Related]
10. Have South Australian isolates of Neisseria meningitidis become less susceptible to penicillin, rifampicin and other drugs? A study of strains isolated over three decades, 1971-1999.
Hansman D; Wati S; Lawrence A; Turnidge J
Pathology; 2004 Apr; 36(2):160-5. PubMed ID: 15203752
[TBL] [Abstract][Full Text] [Related]
11. Rifampin-resistant meningococcal infection in a patient given rifampin chemoprophylaxis.
Berkey P; Rolston K; Zukiwski A; Gooch G; Bodey GP
Am J Infect Control; 1988 Dec; 16(6):250-2. PubMed ID: 3144922
[No Abstract] [Full Text] [Related]
12. A blood isolate of Neisseria meningitidis showing reduced susceptibility to quinolones in Hong Kong.
Chu YW; Cheung TK; Tung V; Tiu F; Lo J; Lam R; Lai R; Wong KK
Int J Antimicrob Agents; 2007 Jul; 30(1):94-5. PubMed ID: 17408928
[No Abstract] [Full Text] [Related]
13. Antimicrobial resistance of Neisseria meningitidis in the United States, 1997. The Active Bacterial Core Surveillance (ABCs) Team.
Rosenstein NE; Stocker SA; Popovic T; Tenover FC; Perkins BA
Clin Infect Dis; 2000 Jan; 30(1):212-3. PubMed ID: 10619761
[No Abstract] [Full Text] [Related]
14. Rifampicin-resistant meningococci causing invasive disease: detection of point mutations in the rpoB gene and molecular characterization of the strains.
Stefanelli P; Fazio C; La Rosa G; Marianelli C; Muscillo M; Mastrantonio P
J Antimicrob Chemother; 2001 Feb; 47(2):219-22. PubMed ID: 11157912
[TBL] [Abstract][Full Text] [Related]
15. Invasive disease caused by Neisseria meningitidis relatively resistant to penicillin in North Carolina.
Woods CR; Smith AL; Wasilauskas BL; Campos J; Givner LB
J Infect Dis; 1994 Aug; 170(2):453-6. PubMed ID: 8035036
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of ciprofloxacin, cefotaxime, ceftriaxone, chloramphenicol, and rifampin against fully susceptible and moderately penicillin-resistant Neisseria meningitidis.
Blondeau JM; Yaschuk Y
Antimicrob Agents Chemother; 1995 Nov; 39(11):2577-9. PubMed ID: 8585750
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic susceptibility of invasive Neisseria meningitidis isolates from 1995 to 2008 in Sweden--the meningococcal population remains susceptible.
Hedberg ST; Olcén P; Fredlund H; Unemo M
Scand J Infect Dis; 2010; 42(1):61-4. PubMed ID: 19883157
[TBL] [Abstract][Full Text] [Related]
18. Penicillin-resistant Neisseria meningitidis bacteraemia, Kimberley region, March 2010.
Abeysuriya SD; Speers DJ; Gardiner J; Murray RJ
Commun Dis Intell Q Rep; 2010 Sep; 34(3):342-4. PubMed ID: 21090191
[TBL] [Abstract][Full Text] [Related]
19. In brief: Meningococcal prophylaxis.
Med Lett Drugs Ther; 2008 Apr; 50(1283):25. PubMed ID: 18391897
[No Abstract] [Full Text] [Related]
20. Fitness Cost of Rifampin Resistance in Neisseria meningitidis: In Vitro Study of Mechanisms Associated with rpoB H553Y Mutation.
Colicchio R; Pagliuca C; Pastore G; Cicatiello AG; Pagliarulo C; Talà A; Scaglione E; Sammartino JC; Bucci C; Alifano P; Salvatore P
Antimicrob Agents Chemother; 2015 Dec; 59(12):7637-49. PubMed ID: 26416867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
